Franziska Eckert

Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy

Lambin, P., Lieverse, R. I. Y., Eckert, F., Marcus, D., Oberije, C., van der Wiel, A. M. A., Guha, C., Dubois, L. J. & Deasy, J. O., Apr 2020, In: Seminars in Radiation Oncology. 30, 2, p. 187-193 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

Lieverse, R. I. Y., Van Limbergen, E. J., Oberije, C. J. G., Troost, E. G. C., Hadrup, S. R., Dingemans, A-M. C., Hendriks, L. E. L., Eckert, F., Hiley, C., Dooms, C., Lievens, Y., de Jong, M. C., Bussink, J., Geets, X., Valentini, V., Elia, G., Neri, D., Billiet, C., Abdollahi, A., Pasquier, D., & 5 othersBoisselier, P., Yaromina, A., De Ruysscher, D., Dubois, L. J. & Lambin, P., 15 Jun 2020, In: BMC Cancer. 20, 1, 10 p., 557.

Research output: Contribution to journal › Article › Academic › peer-review